China NMPA Legal Agent Services
The NMPA Legal Agent is the local authorized representative for any MedTech and IVD manufacturer located outside China. The NMPA* Legal Agent must be a Chinese entity. Just as for submissions in Europe and US, all dossier or product approval submissions to Chinese authorities must be made by the China Agent.
*NMPA stands for the National Medical Products Administration, which is China’s regulatory authority responsible for medical devices.
The official name of the authorized representative role is expected to change from Legal Agent to Domestic Responsible Agent. This was proposed in the draft Medical Device Law which is set to replace the current regulation Order 739. The draft was released in draft format for public comment on August 26, 2024.
Selecting the most appropriate form of Chinese local representation is an important early step in the filing or registration process for your medical device, together with choosing the right agent to ensure compliance and proper representation.
There are 3 broad categories of local representative available to overseas companies:
1
Choosing a Local Distributor
2
Setting Up a Chinese Subsidiary or Legal Entity
3
Appointing an Independent Service Provider
Cisema Acts as an Independent Service Provider of Services for a Growing Number of Companies
Below we set out the advantages and setbacks of each option:
Distributor
Own Subsidiary
Distributor
Role of a China Agent
A China Agent plays a crucial role in applying for medical device and IVD filings and registrations. Acting as the official representative for the foreign companies, the agent is responsible for submitting applications, communicating with the NMPA, and ensuring that all regulatory requirements are met.
This role demands a deep understanding of the Chinese regulatory framework and mandates that the agent be a Chinese legal entity.
By navigating the complexities of the regulatory landscape, the in country representative ensures that the foreign manufacturer’s products comply with local laws, facilitating a smoother entry into the Chinese market.
Responsibilities of an NMPA Legal Agent
They play a critical role throughout the entire product registration process and product lifecycle in China. Acting on behalf of the overseas manufacturer, the legal agent ensures full compliance with relevant regulations issued by the NMPA and the State Council. This includes submitting and maintaining the registration application, managing communications with authorities, and holding a valid business license in China.
The agent is also responsible for adverse event reporting and monitoring, ensuring timely updates and transparency in line with Chinese requirements. They help implement product traceability and an effective recall system to maintain product quality and safeguard public health.
In addition, the legal agent must keep the original NMPA certificate, inform the authorities of any change in the legal manufacturer or appointment of a new agent, and support ongoing regulatory compliance. Their support enables the overseas manufacturer and their Chinese distributor or sales agents to focus on business growth while maintaining regulatory alignment in the country.
Can I Change My Agent?
Yes, changing your Chinese Agent is possible. Manufacturers often consider this when dissatisfied with their current agent, especially if the agent is also their distributor. In such cases, appointing an independent agent like Cisema can provide greater transparency and control.
The process typically takes around seven weeks and requires a copy of the NMPA registration certificate and the Product Technical Requirements (PTR). Obtaining these documents from distributors who handled the original application can sometimes be challenging, but we’re here to help you overcome this hurdle—reach out to us if you're facing this situation.
Can I Become My Own Agent in the Future?
Yes, this is quite common for companies which shift to manufacturing in China. A foreign manufacturer that sets up an organization in China can, in principle, act as their own agent. This local company must satisfy the NMPA's regulatory requirements and is legally responsible for compliance during the entire product life cycle - which includes product registration, post market surveillance, and communication with authorities.
Cisema can remain contracted to assist with communications and post-market surveillance, while some businesses look to adopt this responsibility themselves once local operations are properly set up. Taking on these operational duties in-house allows for greater oversight, but it does mean hiring resources to understand the regulatory framework within China and its changes.
If you’re planning to manufacture in China and wish to eventually act as your own Legal Agent, we can assist in facilitating a seamless transition—feel free to reach out for guidance.
Our China NMPA Legal Agent Services
As your local authorized representative in China, we are your single point of contact for all NMPA matters. As we are independent of any distributor, we ensure that you maintain control of your product registrations and retain an unconstrained choice of your market access partner(s), giving you full flexibility to adapt as necessary to changes in the market.
Our services include:
Prepare, Submit & Follow Up Applications to the NMPA:
Regulatory & Quality Assurance Support for “Made in China” Certification Including:
Other Services Include:
Request a Proposal from our Life Sciences Team about Appointing us or Changing your Agent to Cisema
Let Cisema help turn your plans into reality.
%20Market%20A%20Guide%20for%20Foreign%20Manufacturers%20(1).webp)
Explore Related Services
Whether you’re just starting out or are a blue-chip, access our wide range of services and solutions to help your business thrive.
China Medical Device Registration
We guide you through every step of the China medical device registration and filing process. We take care of compliance with NMPA requirements, advising you on the optimal market entry pathway, and helping you through the whole process.
NMPA Type Testing
We provide end-to-end support for China type testing in NMPA-accredited laboratories. Our experienced test engineers offer on-site supervision to guarantee accurate and reliable results.
China Clinical Trials
You may be required to provide supplementary clinical data on Chinese patients or conduct a full clinical trial in China.Our clinical research team will advise you, prepare the study protocol and assist setting up the clinical trial in China.
NMPA Clinical Evaluation Report
CERs can avoid the need for a China clinical trial in some instances. Our experts can advise and prepare NMPA compliant CERs.
Drug Device Combination Products
We assist with the classification, registration, and compliance of combination products in China, whether drug or device led.
China Medical Device Quality Compliance
We help you achieve and ensure ongoing compliance with Chinese requirements.Our experts prepare and assist you for official NMPA inspections.
Medical Device PMS & Vigilance
The NMPA is placing greater focus on Post-Market Surveillance (PMS) such as more in-market sampling inspections and regular standard changes.
